Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

EC grants orphan drug status to Catalyst Biosciences' CB-2679d

June 29, 2017

Global Blood Therapeutics' GBT-440 obtains EMA PRIME designation

June 29, 2017

Bitopertin shows promise for treating beta-thalassemia-derived anemia

June 29, 2017

Phase II data for voxelotor in pediatric sickle cell disease patients presented

June 28, 2017

Ra Pharmaceuticals reports initial data from study of RA-101495 in PNH

June 28, 2017

Danazol shows promise for treating MDS-associated thrombocytopenia

June 27, 2017

FDA approves Bevyxxa for hospital and extended-duration prophylaxis of VTE

June 26, 2017

FDA approves subcutaneous Haegarda to prevent HAE attacks

June 23, 2017

Merck & Co. divulges coagulation factor XIa/kallikrein B inhibitors

June 23, 2017

ISU Abxis is enrolling patients in phase I trial of ISU-304

June 23, 2017

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...